secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001104659-25-078611
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA Q3 FY2025 revenue $304K, operating loss $3.7M; cash burn improves 19% sequentially
--------------------------------------------------------------------------------

- Total revenues $304K (down 36% YoY from $473K); operating loss $3.7M vs $3.3M loss in prior year.
- Adjusted EBITDA negative $3.9M; monthly net cash burn $934K, down 19% sequentially and 25% YoY.
- Received follow-on LineaDNA order >$600K from IVD manufacturer; added new U.S. mRNA CDMO customer.
- Cash and equivalents $4.7M at June 30, 2025, including $723K from warrant exercises.
- Company closed MDx Testing Services (discontinued ops) and executed 1:15 reverse stock split in June.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465925078611/0001104659-25-078611-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465925078611/tm2523531d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-078611

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer